Patti, Giuseppe
Cavallari, Ilaria
Andreotti, Felicita
CalabrĂ², Paolo
Cirillo, Plinio
Denas, Gentian
Galli, Mattia
Golia, Enrica
Maddaloni, Ernesto http://orcid.org/0000-0003-3844-9463
Marcucci, Rossella
Parato, Vito Maurizio
Pengo, Vittorio
Prisco, Domenico
Ricottini, Elisabetta
Renda, Giulia
Santilli, Francesca
Simeone, Paola
De Caterina, Raffaele
,
Article History
First Online: 24 September 2018
Competing interests
: G.P. is a speaker, consultant, and/or advisory board member for Amgen, AstraZeneca, Bayer, BMS-Pfizer, Boehringer Ingelheim, Daiichi Sankyo, Malesci, MSD, PIAM, Sanofi, and Sigma-Tau. F.A. is a speaker, consultant, and/or advisory board member for Actelion, Amgen, Bayer, BMS-Pfizer, Boehringer Ingelheim, Daiichi Sankyo, International Menarini Foundation, and Medscape. E.M. has received speaker fees from Merck-Serono and grant support from AstraZeneca and Lilly. D.P. is a speaker or has received consultant and/or advisory fees from Bayer, BMS-Pfizer, Boehringer Ingelheim, and Daiichi Sankyo. G.R. has received consultant and speaker fees from Bayer, Boehringer Ingelheim, and Daiichi Sankyo. R.D.C. has received fees from AstraZeneca, Bayer, BMS-Pfizer, Boehringer Ingelheim, Daiichi Sankyo, Lilly, Novartis, and Sanofi-Aventis and has received grant support from AstraZeneca, Bayer, BMS-Pfizer, Boehringer Ingelheim, and Daiichi Sankyo. The other authors declare no competing interests.